ClearPoint Neuro, Inc. financial data

Symbol
CLPT on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
120 S. Sierra Avenue, Suite 100, Solana Beach, California
State of incorporation
Delaware
Fiscal year end
December 31
Former names
MRI INTERVENTIONS, INC. (to 2/11/2020), SURGIVISION INC (to 10/22/2010), SURGI VISION INC (to 5/2/2007)
Latest financial report
10-Q - Q2 2024 - Aug 7, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 374 % -51%
Quick Ratio 73.3 % -49.7%
Debt-to-equity 72.1 % +32.6%
Return On Equity -64.2 % -5.4%
Return On Assets -37.3 % +5.45%
Operating Margin -66.2 % +32%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 27.6M shares +12%
Common Stock, Shares, Outstanding 27.6M shares +12%
Entity Public Float 155M USD -43%
Common Stock, Value, Issued 276K USD +12.2%
Weighted Average Number of Shares Outstanding, Basic 27.5M shares +11.7%
Weighted Average Number of Shares Outstanding, Diluted 27.5M shares +11.7%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 28.1M USD +29.3%
Revenue from Contract with Customer, Excluding Assessed Tax 28.1M USD +29.3%
Cost of Revenue 11.3M USD +35.3%
Research and Development Expense 10.8M USD -11.3%
Selling and Marketing Expense 13.3M USD +17.2%
Operating Income (Loss) -18.6M USD +12%
Net Income (Loss) Attributable to Parent -18M USD +13.7%
Earnings Per Share, Basic -0.7 USD/shares +17.6%
Earnings Per Share, Diluted -0.7 USD/shares +17.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 32.8M USD +24.1%
Accounts Receivable, after Allowance for Credit Loss, Current 3.48M USD +24.2%
Inventory, Net 8.03M USD -12.7%
Assets, Current 46.6M USD +14.4%
Property, Plant and Equipment, Net 1.55M USD +13.6%
Operating Lease, Right-of-Use Asset 3.33M USD -15.8%
Other Assets, Noncurrent 149K USD -4.49%
Assets 52.6M USD +10.4%
Accounts Payable, Current 822K USD -35.4%
Employee-related Liabilities, Current 3M USD +28.1%
Liabilities, Current 16.7M USD +169%
Operating Lease, Liability, Noncurrent 3.3M USD -14.3%
Liabilities 20.4M USD +1.04%
Retained Earnings (Accumulated Deficit) -181M USD -11%
Stockholders' Equity Attributable to Parent 32.1M USD +17.2%
Liabilities and Equity 52.6M USD +10.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -3.84M USD +32.4%
Net Cash Provided by (Used in) Financing Activities 16.1M USD
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 90M shares 0%
Common Stock, Shares, Issued 27.6M shares +12%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 12.2M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 32.8M USD +24.1%
Interest Paid, Excluding Capitalized Interest, Operating Activities 185K USD +3.35%
Deferred Tax Assets, Valuation Allowance 35.8M USD +18.8%
Deferred Tax Assets, Gross 35.9M USD +18.7%
Operating Lease, Liability 3.99M USD +90.7%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Lessee, Operating Lease, Liability, to be Paid 6.35M USD +194%
Property, Plant and Equipment, Gross 2.33M USD -9.36%
Operating Lease, Liability, Current 516K USD +4.67%
Lessee, Operating Lease, Liability, to be Paid, Year Two 954K USD +63.9%
Lessee, Operating Lease, Liability, to be Paid, Year One 869K USD +46.3%
Operating Lease, Weighted Average Discount Rate, Percent 0.12 pure +34.1%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 2.36M USD +3316%
Lessee, Operating Lease, Liability, to be Paid, Year Three 985K USD +103%
Deferred Tax Assets, Operating Loss Carryforwards 30.1M USD +13.4%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 25M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 502K USD +0.4%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 243K USD +88.4%
Deferred Tax Assets, Net of Valuation Allowance 38K USD -2.56%
Share-based Payment Arrangement, Expense 6.43M USD +21.3%
Interest Expense 598K USD -38.8%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%